ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,104Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 973

$596K Total Retail Price of All Prescriptions

Rank: 84 out of 973

434 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 434 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 434 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,897 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 486 441 1 2
SIMVASTATIN 407 362 2 1
AMLODIPINE BESYLATE 390 377 3 7
OMEPRAZOLE 341 278 4 5
LISINOPRIL 313 296 5 3
HYDROCHLOROTHIAZIDE 262 232 6 11
FUROSEMIDE 255 241 7 6
WARFARIN SODIUM 253 231 8 10
PRAVASTATIN SODIUM 217 197 9 22
POTASSIUM CHLORIDE 210 202 10 9
METFORMIN HCL ER 209 204 11 58
LOSARTAN POTASSIUM 173 167 12 19
ALENDRONATE SODIUM 150 137 13 24
METOPROLOL SUCCINATE 147 138 14 17
ATORVASTATIN CALCIUM 142 137 15 15
MIRTAZAPINE 126 124 16 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 101 17 25
METFORMIN HCL 121 116 18 8
LOSARTAN-HYDROCHLOROTHIAZIDE 119 110 19 46
SERTRALINE HCL 111 73 20 21
HYDROCODONE-ACETAMINOPHEN 109 101 S3 21 4
TRAMADOL HCL 104 94 22 18
ZOLPIDEM TARTRATE 100 79 23 20
CITALOPRAM HBR 100 92 23 14
DONEPEZIL HCL 99 99 25 26
CRESTOR 98 98 26 34
FAMOTIDINE 91 90 27 61
NEXIUM 89 74 28 30
ATENOLOL 85 73 29 16
SYNTHROID 83 68 30 50
METOPROLOL TARTRATE 81 81 31 13
PAROXETINE HCL 77 77 32 66
DIGOXIN 77 77 32 32
GABAPENTIN 75 72 34 12
SPIRONOLACTONE 74 74 35 49
CYMBALTA 73 61 36 40
ALLOPURINOL 73 73 36 29
SPIRIVA 72 72 38 73
TRIAMTERENE-HCTZ 71 65 39 51
CARVEDILOL 69 69 40 27
ETODOLAC 68 63 41 179
CELEBREX 67 50 42 91
DILTIAZEM ER 66 66 43 109
MELOXICAM 64 59 44 23
METOCLOPRAMIDE HCL 57 55 45 93
PREDNISONE 55 47 46 33
NAMENDA 55 55 46 31
POLYETHYLENE GLYCOL 3350 55 39 46 36
TAMSULOSIN HCL 55 41 46 28
BENAZEPRIL HCL 54 52 50 62
AMLODIPINE BESYLATE-BENAZEPRIL 54 42 50 80
DEXILANT 53 48 52 213
CLONIDINE HCL 53 53 52 67
BYSTOLIC 53 51 52 110
LANTUS SOLOSTAR 52 35 55 99
TERAZOSIN HCL 51 41 56 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.